English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17778/20119 (88%)
Visitors : 12251638      Online Users : 299
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/28629

    標題: Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP-2
    作者: Liao, Alex Chien Hwa
    Kuo, Chia-Cheng
    Huang, Yei-Chung
    Yeh, Chi-Wei
    Hseu, You-Cheng
    Liu, Jer-Yuh
    Hsu, Li-Sung
    貢獻者: 老人服務事業管理系
    關鍵字: bladder cancer
    matrix metalloproteinase-2
    日期: 2014-09
    上傳時間: 2015-05-06 21:23:06 (UTC+8)
    出版者: Spandidos Publ Ltd
    摘要: Bladder cancer is one of the causes of cancer-related death and has a high mortality rate due to its metastatic ability. Naringenin, a bioactive compound predominantly found in citrus fruits, exhibits several cellular functions, including anti-oxidant, -lipidemia and -cancer abilities. However, the effects of naringenin on bladder cancer cells are yet to be elucidated. The present study investigated the molecular mechanisms underlying the effects of naringenin on the migration of TSGH-8301 bladder cancer cells. Treatment with naringenin at doses ranging between 0 and 300 mu M over a period of 24 h was found to reduce cell viability. Furthermore, zymography and western blot analysis revealed that naringenin reduced the expression of matrix metalloproteinase (MMP)-2 in a dose-dependent manner, and repressed its activity. Naringenin also reduced TSGH-8301 cell migration in a concentration-dependent manner, as evidenced by wound healing and Transwell (R) assays. In addition, naringenin was found to inhibit AKT activity and block the nuclear translocation of nuclear factor x-light-chain-enhancer of activated B cells. In conclusion, the findings of the present study show that naringenin is capable of inhibiting bladder cancer cell migration through the downregulation of the AKT and MMP-2 pathways.
    關聯: Molecular Medicine Reports, v.10 n.3, pp.1531-1536
    Appears in Collections:[老人服務事業管理系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    28629.pdf653KbAdobe PDF454View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback